AFP and hepatocellular carcinoma: In conclusion, EOT-AFP ≥5.3 ng/mL is a useful marker for predicting the development of HCC after an SVR; however, the AFP level did not increase in patients with EOT-AFP <5.3 ng/mL at the onset of HCC.